MediMusic is a B2B service that uses artificial intelligence and machine learning to create audio fingerprints which mimic the human brain’s response to music and then scientifically dispense it as an efficacy-driven medicine for the benefit of clinical pain and anxiety.
We auto-create personalised, smart playlists that use predictive analysis to reduce heart rate and the stress hormone Cortisol, thereby promoting positive endocrine secretions – such as Dopamine, Immunoglobin-A and Oxytocin – as well as improving breathing and cognitive response.
MediMusic disrupts the current clinical practice of music therapy by creating a scalable, service, that streams personalised 25-minute playlists via an app, designed to positively influence the physiological and neurological functions of the human body.
Monitoring the user heart rate response, via our Digital Drip® bio feedback loop, refines the service providing evidence based, cost benefit KPIs for healthcare services.
© The content on this page is provided by the profiled company, and remains their copyright.
Hessle
2020
1-10 people
Currently raising Seed B
